Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling (Q34512406)

2 August 2017

title

Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling (English)

1 reference

2 August 2017

3

Kelly Chibale

1 reference

2 August 2017

Pierre Redelinghuys

1

1 reference

2 August 2017

Aloysius T Nchinda

series ordinal

2

1 reference

2 August 2017

Edward D Sturrock

series ordinal

4

1 reference

2 August 2017

publication date

1 April 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

387

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

461-466

1 reference

Ace revisited: a new target for structure-based drug design.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Angiotensin-converting enzyme: new concepts concerning its biological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Crystal structure of the human angiotensin-converting enzyme-lisinopril complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

The preparation and function of the hypertensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

Identification of N-linked glycosylation sites in human testis angiotensin-converting enzyme and expression of an active deglycosylated form

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.061

21 January 2018

Identifiers

DOI

10.1515/BC.2006.061

1 reference

release_crt3gmzbfnellhllnc3xgcwjgm

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/crt3gmzbfnellhllnc3xgcwjgm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference